Akari Therapeutics (AKTX) jumps on preclinical AKTX-101 + KRAS inhibitor synergy in pancreatic cancer; learn what it means ...
A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: ...
Researchers have advanced colon-on-a-chip models to deepen studies of inflammatory bowel disease. Chips included two types of ...
A new stem-cell-derived model suggests human pancreatic cells require multiple genetic failures before becoming cancerous and ...
Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized ...
Spatial and single-cell analyses of human donor pancreata showed that PanIN epithelial cells gradually acquire cancer-like molecular features, while their surrounding stromal and immune environment ...
Christian Pilarsky vividly remembers the moment, in 2022, when he realized that his technique for modelling pancreatic cancer had finally worked. A molecular biologist at the University Hospital ...
An ADC with a novel RNA spliceosome modulating payload PH1 paired with a KRAS inhibitor demonstrates synergistic cytotoxic ...
Poplaski’s photo shoot with the Cancer Compassionate Collection by Bryght. She was chosen out of 250 people to be the company’s 2025 Strength and Courage model Submitted Artwork Poplaski poses for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results